Conspiracy to Deflect Attention from Opioid's Deadly Addiction Potential - Hallo friendsDARMO NEWS TODAY, In the article you read this time with the title Conspiracy to Deflect Attention from Opioid's Deadly Addiction Potential, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article culture, Article economy, Article health, Article healthy tips, Article news, Article politics, Article sports, We write this you can understand. Alright, good read.

Title : Conspiracy to Deflect Attention from Opioid's Deadly Addiction Potential
link : Conspiracy to Deflect Attention from Opioid's Deadly Addiction Potential

Conspiracy to Deflect Attention from Opioid's Deadly Addiction Potential

The Secret Opioid Memo That Could Have Slowed or Prevented an Epidemic
As is the norm... It’s been long, long known that OxyContin, would fuel an abuse and addiction crisis. And this knowledge was intentionally swept under the rug

A confidential government document containing evidence so critical it had the potential to change the course of an American tragedy was kept in the dark for more than a decade. The document, known as a “prosecution memo,” details how government lawyers believed that Purdue Pharma, the maker of the powerful opioid, OxyContin, knew early on that the drug was fueling a rise in abuse and addiction. They also gathered evidence indicating that the company’s executives had misled the public and Congress.

So, the document containing evidence so critical of Oxycontin aka Opioids deadly addiction potential was kept confidential for more then decade? And why was that?

“The Weekly” shines a light on that 2006 Justice Department memo and its consequences for today’s wave of lawsuits against opioid makers and members of the Sackler family, which owns Purdue Pharma. We go with Barry Meier, the New York Times reporter who for two decades has chronicled how opioid abuse has ravaged America, as he travels back to where the crisis began.

LATimes

Big Pharma's Soul Destroying Profiteering

As the nation’s opioid crisis deepened over the last decade, drug makers and distributors worked to deflect attention from their own roles in creating widespread addiction, according to lawyers for hundreds of cities, counties, tribes and other entities suing key pharmaceutical industry players.

One drug distributor highlighted the roles of “pill mills,” unethical doctors and pharmacies that dished up narcotic painkillers by the millions, court records state. Another focused on prescriptions acquired illegally from friends and relatives.

But Purdue Pharma, the maker of the widely abused painkiller OxyContin, considered a different tack.

Internal documents from 2016 show company officials discussed diverting online traffic away from a series of stories published by the Los Angeles Times that detailed the company’s marketing of OxyContin and its links to the deadly opioid crisis.
“If Purdue doesn’t fill this vacuum, someone else will — and it won’t be Purdue’s narrative,” a member of the company’s digital support team wrote in a memo to Purdue officials, laying out a strategy to drive traffic to a friendly website, PurduePharmaFacts.com.

“By purchasing highly targeted strings of keywords that people are likely to use to find out more information about the articles, we can ensure that PurduePharmaFacts.com is at the top of a user’s search results,” a related PowerPoint presentation stated.

“We’ve tailored the recommendation to capture only people searching for information related to the Times articles and to not interfere with Purdue’s marketing efforts surrounding OxyContin or spark curiosity where there was none before,” it said.

The Times’ 2016 investigative series showed how decisions by Purdue, a Connecticut corporation owned by the Sackler family, fueled the opioid epidemic. The newspaper found that OxyContin, the company’s best-selling product, wears off hours earlier than its advertised 12-hour duration in many patients, exposing them to increased risk of addiction. It also described how the company’s lawyers and security department gathered extensive evidence suggesting specific doctors and pharmacies across the nation were engaged in drug trafficking, but did not shut off the flow of OxyContin to them and, in many cases, did not share the information with law enforcement.

Purdue, which by 2016 had collected more than $31 billion from OxyContin sales, disputed The Times’ findings.

U.S. opioid overdose deaths rose from 8,048 in 1999 to 47,600 in 2017, according to the Centers for Disease Control and Prevention.

Opioid deaths increased more then 5X in about 18 years. Profitable, but, not problematic?
Apparently not for the drug makers or for the government? 

I know, I know... let's blame "climate change"!

Related:

As Whooping Cough Evolves- How to Maintain Vaccine Effectiveness?

Thus Article Conspiracy to Deflect Attention from Opioid's Deadly Addiction Potential

That's an article Conspiracy to Deflect Attention from Opioid's Deadly Addiction Potential This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Conspiracy to Deflect Attention from Opioid's Deadly Addiction Potential with the link address https://darmonewst.blogspot.com/2019/08/conspiracy-to-deflect-attention-from.html

Tweet

Subscribe to receive free email updates: